 Wysłany: Sob 21:53, 26 Lut 2011 Temat postu: Bcl-2 protein, Ki-67 antigen, estrogen receptor an |
|
| Bcl-2 protein, Ki-67 antigen, estrogen receptor and progesterone receptor in adenomyosis endometrial carcinoma
, Eta1. Uterinearteryembolizafionforadenomyosiswithoutfibroids. ClinRadiol. 2004,belstaff outlet,59:520-526.2 EzakiK, MotoyamaH, SasakiH. Immunohistologiclocalizationofestronesulfataseinuterineendometriumandadenomyosis. ObstetGynecol ,p90x workout calendar,2001,98:815-819 .3 GhobrialIM, WitzigTE, AdjeiAA. Targetingapoptosispathwaysincancertherapy. CAcancerJClin ,2005,55:178-194 .4 Qinx, ShigekiT, NoriyukiO, eta1. ProgesteronereceptormodulatorCDB ·-2914down · · regulatesproliferativecellnuclearantigenandbcl - 2proteinexpressionandup · regulatescaspase a 3andpoly (Adenosine5 a diphosphate-ribose) polymeraseexpressioninculturedhumanuterineleiomyomacells. JClinEndocrinolMetab ,2005,supra for sale,90:953-961 .5 MaiaHJ, MaltezA, StudartE, eta1. Effectofmenstrualcycleandhormonaltreatmentonki-67andbcl · 2expressionandadenomyosis. GynecolEndocrinol ,2005,20:127-131 .6 MaiaHJ, MaltezA, StudartE, eta1. Proliferationkineticsinadeno-myosisduringtheme ~ tmalcycleandduringoralcontraceptiveuse. GynecolEndocrinol,ghd piastre, 2004, l8: l0l a 106.7NasuK, NishidaM, UedaT, eta1. Applicationofthenuclearfactor-kappaBinhibitor, BAY11-7085, forthetreatmentofendometriosis: aninvitrostudy. AmJPhysiolEndocrinolMetab, 2OO6 ,8:771-776 .8 NishidaM, NasuK, UedaT, eta1. B · HydroxyisovalerylshikonininducesapoptosisandG0/GIcell · cyclearrestofendometrioticstromalcells: apreliminaryinvitrostudy. HumReprod ,2006,6:283-288 .9 NasuK, NishidaM, UedaT,tory burch outlet, eta1. BufalininducesapoptosisandtheG0/GIcellcyclearrestofendometrioticstromalcells: apromisingagentforthetreatmentofendometriosis. MolHumReprod, 2005,11:8 l723. |
|
